Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin

Vaccine

Volumn 15, Issue 3, 1997, Pages 257-264

  Porter, Donna C ^a   Wang, Jun ^a   Moldoveanu, Zina ^a   McPherson, Sylvia ^a   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

C fragment tetanus toxin; immune response; poliovirus; protection; replicon; vaccine vector

Indexed keywords

CAPSID PROTEIN; TETANUS TOXIN; TETANUS TOXOID; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROVOCATION TEST; REPLICON; TETANUS;

ANIMALS; CELLS, CULTURED; GENETIC VECTORS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; POLIOVIRUS; REPLICON; TETANUS TOXIN; TETANUS TOXOID; VACCINES, INACTIVATED;

EID: 0031044255     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00187-9     Document Type: Article

References (47)

1. Kitamura, N., Semler, B.L., Rothberg, P.G. et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (London) 1981, 291, 547-553
2. Koch, F. and Koch, G. The Molecular Biology of Poliovirus. Springer-Verlag, Vienna, 1985
3. Palmenberg, A.C. Proteolytic processing of picomaviral polyprotein. A. Rev. Microbiol. 1990, 44, 603-623
4. Racaniello, V. and Baltimore, D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 1981, 214, 916-919
5. Semler, B.L., Dorner, A.J. and Wimmer, E. Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res. 1984, 12, 5123-5141
6. Cole, C.N. Defective interfering (DI) particles of poliovirus. Prog. Med. Virol. 1975, 20, 180-207
7. Hagino-Yamagishi, K. and Nomoto, A. In vitro construction of poliovirus defective interfering particles. J. Virol. 1989, 63, 5386-5392
8. Kaplan, G. and Racaniello, V.R. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 1988, 62, 1687-1696
9. Anderson, M.J., Porter, D.C., Fultz, P.M. and Morrow, C.D. Poliovirus replicons that express the Gag or the envelope surface protein of simian immunodeficiency virus SIVsmm PBJ14. Virology 1996, 140-149
10. Ansardi, D.C., Moldoveanu, Z., Porter, D.C. et al. Characterization of poliovirus replicons encoding carcinoembryonic antigens. Cancer Res. 1994, 54, 6359-6363
11. Choi, W.-S., Pal-Ghosh, R. and Morrow, C.D. Expression of human immunodeficiency virus type 1 HIV-1 gag, pol and env proteins from chimeric HIV-1-poliovirus minireplicons. J. Virol. 1991, 65, 2875-2883
12. Percy, N., Barclay, W.S., Sullivan, M. and Almond, J.W. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J. Virol. 1992, 66, 5040-5046
13. Porter, D.C., Ansardi, D.C. and Morrow, C.D. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type l gag gene using a complementation system which provides the P1 capsid protein in trans. J. Virol. 1995, 69, 1548-1555
14. Porter, D.C., Melsen, L.R., Compans, R.W. and Morrow, C.D. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. J. Virol. 1996, 70, 2643-2649
15. Ansardi, D.C., Porter, D.C. and Morrow, C.D. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans. J. Virol. 1993, 67, 3684-3690
16. Ansardi, D.C., Pal-Ghosh, R., Porter, D.C. and Morrow, C.D. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. J. Virol. 1995, 69, 1359-1366
17. Morrow, C.D., Porter, D.C., Ansardi, D.C., Moldoveanu, Z. and Fultz, P.M. New approaches for mucosal vaccines for AIDS: encapsidation and serial passage of poliovirus replicons which express HIV-1 proteins upon infection. AIDS Res. Hum. Retroviruses 1994, 10, S61-S66
18. Morrow, C.D., Porter, D.C. and Ansardi, D.C. New methods to study poliovirus assembly and encapsidation of genomic RNA. In: Methods in Molecular Genetics, Viral Gene Techniques (Ed. Adolph, K.W.). Academic Press, Orlando, FL, 1995, Vol. 7, Chap. 19, pp. 299-314
19. Morrow, C.D., Ansardi, D.C. and Porter, D.C. Methods for the use of poliovirus vectors for gene delivery. In: Gene Therapy Protocols, Methods in Molecular Biology (Ed. Robbins, P.). The Humana Press, Totowa, New Jersey, 103-106
20. Porter, D.C., Ansardi, D.C., Choi, W.S. and Morrow, C.D. Encapsidation of genetically engineered poliovirus minireplicons which express HIV-1 gag and pol proteins upon infection. J. Virol. 1993, 67, 3712-3719
21. Ren, R., Costantini, F.C., Gorgacz, E.J., Lee, J.J. and Racaniello, V.R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990, 63, 353-362
22. Moldoveanu, Z., Porter, D.C., Lu, A., McPherson, S. and Morrow, C.D. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine 1995, 13, 1013-1022
23. Charles, I.G., Rodgers, B.C., Makoff, A.J., Chatfield, S.N., Slater, D.E. and Fairweather, N.F. Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system. Infect. Immun. 1991, 59, 1627-1632
24. Helting, T.B., Zwisler, O. Structure of tetanus toxin. J. Biol. Chem. 1977, 252, 187-193
25. Romanos, M.A., Makoff, A.J., Fairweather, N.F. et al. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res. 1991,19, 1461-1466
26. Ansardi, D.C., Porter, D.C. and Morrow, C.D. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 1991, 65, 2088-2092
27. Palker, T.J., Matthews, T.J., Clark, M.E. et al. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. natn. Acad. Sci. U.S.A. 1987, 84, 2479-2483
28. Palker, T.J., Clark, M.E., Langlois, A.J. et al. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. natn. Acad. Sci. U.S.A. 1988, 85, 1932-1936
29. Palker, T.J., Matthews, T.J., Langlois, A. et al. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J. Immun. 1989, 142, 3612-3619
30. Oxer, M.D., Bentley, C.M., Doyle, J.G., Peakman, T.C., Charles, I.G. and Makoff, A.J. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic Acids Res. 1991, 19, 2889-2892
31. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989
32. Morrow, C.D., Moldoveanu, Z., Anderson, M.J. and Porter, D.C. Poliovirus replicons as a vector for mucosal vaccines. In: Mucosal Vaccines (Eds Kiyono, H., McGhee, J. and Ogra, P.). Academic Press, 137-144
33. pol. Virus Res. 1993, 29, 241-254
34. Altmeyer, R., Escriou, N., Girard, M., Palmenberg, A. and van der Werf, S. Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc. natn. Acad. Sci. U.S.A. 1994, 91, 9775-9779
35. Andino, R., Silvera, D., Suggett, S.D. et al. Engineering poliovirus as vaccine vector for the expression of diverse antigens. Science 1994, 265, 1448-1451
36. Makoff, A.J., Oxer, M.D., Romanos, M.A., Fairweather, N.F. and Ballantine, S. Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res. 1989, 17, 10191-10202
37. Bass, J.W., Holstead, S.B., Fischer, G.W., Podgore, U.K. and Wiebe, R.A. Effect of booster vaccination one to 14 years after primary series. J. Am. Med. Assoc. 1978, 239, 2252-2255
38. Hanson, L.A., Carlsson, B., Jalil, F., Lindblad, B.S., Khan, S.R. and van Wezel, A.L. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines. Rev. Infect. Dis. 1984, 6, S356-S360
39. Ogra, P.L., Karzon, D.T., Righthand, F. and MacHillivray, M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med. 1968, 279, 893-900
40. Ogra, P.L. and Karzon, D.T. Formation and function of poliovirus antibody in different tissues. Prog. Med. Virol. 1971, 13, 56-193
41. Ogra, P.L. and Ogra, S.S. Local antibody response to poliovaccine in the human female genital tract. J. Immun. 1973, 110, 1307-1311
42. Ogra, P.L. Mucosal immune response to poliovirus vaccines in childhood. Rev. Infect. Dis. 1984, 6, S361-S368
43. Ogra, P.L., Leibovitz, E.E., Zhao-Ri, G. Oral immunization and secretory immunity to viruses. Curr. Top. Microbiol. Immun. 1989, 146, 73-81
44. Sabin, A.B. and Boulger, L.R. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1973, 1, 115-118
45. Sanders, D.Y. and Cramblett, H.G. Antibody liters to polioviruses in patients ten years after immunization with Sabin vaccine. J. Fed. 1974, 84, 406-408
46. Graham, S., Wang, E.C.Y, Jenkins, O. and Borysiewicz, L.K. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J. Virol. 1993, 67, 1627-1637
47. Simons, J., Kutubuddin, M. and Chow, M. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 1993, 67, 1262-1268